Full metadata record

DC Field Value Language
dc.contributor.authorKwak, Eunji-
dc.contributor.authorKim, Taehyung-
dc.contributor.authorYang, Kyungjik-
dc.contributor.authorKim, Young Min-
dc.contributor.authorHan, Hwa Seung-
dc.contributor.authorPark, Kyung Hoon-
dc.contributor.authorChoi, Ki Young-
dc.contributor.authorRoh, Young Hoon-
dc.date.accessioned2024-01-19T12:00:44Z-
dc.date.available2024-01-19T12:00:44Z-
dc.date.created2022-07-08-
dc.date.issued2022-06-
dc.identifier.issn1525-7797-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/115122-
dc.description.abstractTo date, the application of RNA therapeutics to hematologic malignancies has been challenging owing to the resistance of blood cancer cells against conventional transfection methods. Herein, triple-targeting moiety-functionalized polymeric small interfering RNA (siRNA) nanopartides were systematically developed for efficient targeted delivery of RNA therapeutics to hematologic cancer cells. Polymeric siRNAs were synthesized using rolling circle transcription and were surface-functionalized with three types of targeting moieties-a natural ligand and two additional combinations of cell-specific antibodies-for tunable targetability. As a proof of concept, the optimization of the hyaluronic acid/antibody conjugation ratio was performed for selective intracellular delivery to various non-Hodgkin's lymphoma (NHL) cell lines (Daudi, Raji, Ramos, and Toledo cells) via receptor-mediated endocytosis. The engineered nanopartides showed almost 10-fold enhanced NHL-specific intracellular delivery and induced significant in vitro anticancer effects. This multitargeted nanopartide platform may effectively support the intracellular delivery of polymeric siRNA sequences, and thus promote therapeutic effects in hematopoietic malignancies.-
dc.languageEnglish-
dc.publisherAmerican Chemical Society-
dc.titleSurface-Functionalized Polymeric siRNA Nanoparticles for Tunable Targeting and Intracellular Delivery to Hematologic Cancer Cells-
dc.typeArticle-
dc.identifier.doi10.1021/acs.biomac.1c01497-
dc.description.journalClass1-
dc.identifier.bibliographicCitationBiomacromolecules, v.23, no.6, pp.2255 - 2263-
dc.citation.titleBiomacromolecules-
dc.citation.volume23-
dc.citation.number6-
dc.citation.startPage2255-
dc.citation.endPage2263-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000813770400001-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.relation.journalWebOfScienceCategoryPolymer Science-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalResearchAreaPolymer Science-
dc.type.docTypeArticle-
dc.subject.keywordPlusRNA INTERFERENCE-
dc.subject.keywordPlusCROSS-LINKING-
dc.subject.keywordPlusLYMPHOMA-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordPlusAPOPTOSIS-
dc.subject.keywordPlusRITUXIMAB-
dc.subject.keywordPlusGENE-
dc.subject.keywordPlusCHOP-
dc.subject.keywordPlusMICROSPONGES-
dc.subject.keywordPlusNANOCARRIERS-
Appears in Collections:
KIST Article > 2022
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE